
1. Technology overview
Jmees Inc. is a medical AI company located in Kashiwa, Chiba, Japan. It develops AI programs that support organ recognition during surgery, aiming to improve safety in operating rooms where surgeons rely on tacit knowledge of anatomy.
SurVis is a family of endoscopic surgery support programs. The AI analyzes the endoscopic video during an operation and highlights important anatomical structures on the monitor to support the surgeon's recognition of organs. Two products are listed: SurVis-Hys for total hysterectomy and SurVis-Pel for pelvic and lateral lymph node dissection. The company also offers Nurscope Connect, a smartphone app and viewer that supports bowel preparation before colonoscopy.
2. Highlighted features & specifications
- SurVis-Hys: Endoscopic surgery support program for total hysterectomy.
- SurVis-Pel: Support program for pelvic and lateral lymph node dissection, announced as approved in March 2026.
- Organ recognition support: AI analyzes surgical video and emphasizes important structures on screen.
- Clinical co-development: Developed together with the National Cancer Center Hospital East.
- Nurscope Connect: Smartphone app and viewer for bowel preparation assessment before colonoscopy.
3. Potential application
Gynecologic and colorectal cancer surgery units in large hospitals could use the programs as a second pair of eyes during laparoscopic operations. Training hospitals could use the highlighted structures to teach residents. Endoscopy centers could use Nurscope Connect to check bowel preparation quality.
4. Benefits
Highlights key anatomical structures on the monitor during endoscopic surgery. Supports less experienced surgeons by making expert judgment more visible. Aims to reduce surgeon burden and improve surgical safety. Backed by a validation study with 36 surgeons for the pelvic lymph node dissection AI.
5. Market trends & opportunities
Surgical AI that supports anatomy recognition is growing as hospitals look for ways to reduce complications and standardize skill across surgeons. Japan has approved several surgical video analysis programs, and hospitals in Vietnam and Southeast Asia with growing laparoscopic caseloads may look for similar decision support.
6. Other information
Based in Kashiwa, Chiba, Japan. SurVis-Pel co-developed with the National Cancer Center Hospital East; SurVis-Hys sales began in July 2025; adopted into an AMED medical-engineering global expansion program (August 2025); won first place in two MICCAI tasks in two consecutive years.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































